- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cannara Biotech Inc (LOVE)
Cannara Biotech Inc stock price live, this page displays TSX LOVE stock exchange data. View the LOVE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cannara Biotech Inc real time stock price chart below.
What Is the Cannara Biotech Inc Stock Price Today?
The Cannara Biotech Inc stock price today is 1.8400.
What Is the Stock Symbol for Cannara Biotech Inc?
The stock symbol for Cannara Biotech Inc is "LOVE."
What Stock Exchange Does Cannara Biotech Inc Trade On?
Cannara Biotech Inc is listed and trades on the Toronto stock exchange.
Is Cannara Biotech Inc a Good Stock to Buy?
Determining whether Cannara Biotech Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LOVE quote. (ISIN: CA13765U2002)
What Is the Cannara Biotech Inc Stock Price Today?
The Cannara Biotech Inc stock price today is 1.8400.
What Is the Stock Symbol for Cannara Biotech Inc?
The stock symbol for Cannara Biotech Inc is "LOVE."
What Stock Exchange Does Cannara Biotech Inc Trade On?
Cannara Biotech Inc is listed and trades on the Toronto stock exchange.
Is Cannara Biotech Inc a Good Stock to Buy?
Determining whether Cannara Biotech Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LOVE quote. (ISIN: CA13765U2002)
Toronto
Currency in CAD
1.8400
+0.0100(+0.55%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.8100
1.9200
52 wk Range
1.0800
2.0700
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.81001.9200
52 wk Range
1.08002.0700
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
LOVE Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
3.1875
Upside
+73.23%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Operates with a moderate level of debt
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
Cannara Biotech Inc Earnings Call Summary for Q1/2026
- Cannara Biotech reported Q1 2026 net revenue of CAD 30.1 million (up 20% YoY), record 45% gross margin, and adjusted EBITDA of CAD 8.8 million (up 47% YoY)
- Despite challenging market conditions with declining Canadian retail cannabis sales, Cannara increased national retail sales by 3% while maintaining position as top producer in Quebec
- The company plans to invest CAD 30 million over three years to double production capacity, targeting maintained 45% gross margins with focus on Quebec and Ontario markets
- Management emphasized vertical integration as key to profitability, describing their business as 'a scalable cash-generating platform with a proven playbook' for growth
- Stock price fell 1.71% post-earnings to CAD 1.75 despite strong financial performance, with company forecasting substantial revenue growth through FY2027
Last Updated: 02/03/2026, 02:52 AM
Read Full TranscriptCompare LOVE to Peers and Sector
Metrics to compare | LOVE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLOVEPeersSector | |
|---|---|---|---|---|
P/E Ratio | 17.8x | −3.0x | 12.1x | |
PEG Ratio | −0.82 | 0.03 | 0.03 | |
Price/Book | 1.5x | 1.0x | 1.5x | |
Price / LTM Sales | 1.6x | 1.7x | 0.9x | |
Upside (Analyst Target) | 70.8% | 69.3% | 21.7% | |
Fair Value Upside | Unlock | 11.0% | 11.0% | Unlock |
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 3.1875
(+73.23% Upside)
Earnings
Latest Release
Jan 26, 2026
EPS / Forecast
0.01 / --
Revenue / Forecast
30.11M / --
People Also Watch
FAQ
What Is the Cannara Biotech (LOVE) Stock Price Today?
The Cannara Biotech stock price today is 1.8400 CAD.
What Stock Exchange Does Cannara Biotech Trade On?
Cannara Biotech is listed and trades on the Toronto Stock Exchange.
What Is the Stock Symbol for Cannara Biotech?
The stock symbol for Cannara Biotech is "LOVE."
What Is the Cannara Biotech Market Cap?
As of today, Cannara Biotech market cap is 180.7700M CAD.
What Is Cannara Biotech's Earnings Per Share (TTM)?
The Cannara Biotech EPS (TTM) is 0.1087.
From a Technical Analysis Perspective, Is LOVE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Cannara Biotech Stock Split?
Cannara Biotech has split 1 times.
How Many Employees Does Cannara Biotech Have?
Cannara Biotech has 452 employees.
What is the current trading status of Cannara Biotech (LOVE)?
As of Apr 23, 2026, Cannara Biotech (LOVE) is trading at a price of 1.8400 CAD, with a previous close of 1.8300 CAD. The stock has fluctuated within a day range of 1.8100 CAD to 1.9200 CAD, while its 52-week range spans from 1.0800 CAD to 2.0700 CAD.
What Is Cannara Biotech (LOVE) Price Target According to Analysts?
The average 12-month price target for Cannara Biotech is 3.1875 CAD, with a high estimate of 3.5 CAD and a low estimate of 3 CAD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +73.23% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.